Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Eptifibatide Injection

Approval Number

国药准字H20120093

Company山西德元堂药业有限公司

Registration Date

May 16, 2022

Previous Approval Numbers

国药准字H20120093

Drug Information

Generic Name

依替巴肽注射液

Dosage Form

注射剂

Strength

10ml:20mg

Drug Type

化学药品

Registration Date

May 16, 2022

Company Information

Applicant Company

Company Name山西德元堂药业有限公司

Company Address

山西省晋中市山西示范区晋中开发区汇通产业园区开发区机械园

Manufacturing Company

Company Name山西德元堂药业有限公司

Company Address

山西省晋中市山西示范区晋中开发区汇通产业园区开发区机械园

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy